Universe · entity
Bain Capital Life Sciences Investors, LLC
Institutional manager (13F) · CIK 1703031
13F holdings · as of 2026-03-31 · top 20 · reported portfolio $1.1B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | HEARTFLOW INC | $254M | 10,448,158 |
| 2 | NEWAMSTERDAM PHARMA COMPANY | $234M | 7,306,566 |
| 3 | OLEMA PHARMACEUTICALS INC | $111M | 7,473,238 |
| 4 | SAVARA INC | $96M | 17,600,621 |
| 5 | PHARVARIS N V | $76M | 2,675,509 |
| 6 | SOLID BIOSCIENCES INC | $71M | 9,808,819 |
| 7 | X4 PHARMACEUTICALS INC | $33M | 7,967,454 |
| 8 | DIANTHUS THERAPEUTICS INC | $30M | 362,470 |
| 9 | ANNEXON INC | $29M | 5,212,674 |
| 10 | KYVERNA THERAPEUTICS INC | $27M | 3,110,000 |
| 11 | CABALETTA BIO INC | $26M | 9,677,125 |
| 12 | CENTESSA PHARMACEUTICALS | $25M | 635,000 |
| 13 | ALKERMES PLC | $22M | 610,000 |
| 14 | RAPID MICRO BIOSYSTEMS INC | $19M | 8,434,560 |
| 15 | C4 THERAPEUTICS INC | $19M | 7,171,910 |
| 16 | ATEA PHARMACEUTICALS INC | $13M | 2,360,638 |
| 17 | DISC MEDICINE INC | $9M | 141,234 |
| 18 | UPSTREAM BIO INC | $8M | 867,211 |
| 19 | XILIO THERAPEUTICS INC | $6M | 664,021 |
| 20 | NEWAMSTERDAM PHARMA COMPANY | $2M | 99,999 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.